Amphion Innovations plc Acquires 35% Stake in Manchester Molecular Diagnostic Spin-out Company.
Business Wire › November 27, 2006
Linked as:
Extract
Amphion Innovations plc Acquires 35% Stake in Manchester Molecular Diagnostic Spin-out Company.
LONDON -- Amphion Innovations plc, the developer of life science and medical technology businesses, announces today that it has invested [pounds sterling]1 million in its latest Partner Company, Myconostica Ltd, an award winning University of Manchest...
See the full content of this document
Sponsored links
